{"id":2838,"date":"2020-09-04T09:00:00","date_gmt":"2020-09-04T09:00:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/xvivo-perfusion-strengthens-the-management-team-with-the-addition-of-a-new-commercial-director-and-rd-director\/"},"modified":"2020-09-04T09:00:00","modified_gmt":"2020-09-04T09:00:00","slug":"xvivo-perfusion-strengthens-the-management-team-with-the-addition-of-a-new-commercial-director-and-rd-director","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-strengthens-the-management-team-with-the-addition-of-a-new-commercial-director-and-rd-director\/","title":{"rendered":"XVIVO Perfusion strengthens the management team with the addition of a new Commercial Director and R&D Director"},"content":{"rendered":"
\n

XVIVO informs today that Johan Holmstr\u00f6m has joined the company as Commercial Director and Charlotte Walldal as R&D Director.\u00a0Both persons will become members of the executive team.<\/p>\n

Johan Holmstr\u00f6m\u2018s main task is to develop XVIVO\u2019s commercial strategy and lead the necessary change agenda to realize the company\u2019s growth agenda.\u00a0He has held leading positions with M\u00f6lnlycke Health Care and lately with Lehmann Rauscher and Permobil. Johan is entering into his new position with immediate effect.
\u00a0
Charlotte Walldal will assume responsibility for basis research and development, which is a prerequisite for XVIVO\u2019s ability to, not only maintain, but also strengthen its world leading position within the field of solutions for transplants. Charlotte has a long career in leading positions within Essity, with focus on R&D. She will start in her new position on October 1, 2020.<\/p>\n

XVIVO Perfusions CEO Dag Andersson says in a comment related to both appointments; \u201cI am very pleased that we have succeeded in recruiting two highly qualified individuals in areas which are so central for our future development. With Charlotte and Johan joining our team we have every possibility for future growth and have all conditions in place to become an even more complete and successful company\u201d.<\/p>\n<\/div>\n

\n

For further information, please contact:<\/strong><\/p>\n\n

Dag Andersson,\u00a0CEO, +46 31-788 21 50,\u00a0dag.andersson@xvivoperfusion.com<\/a><\/p>\n<\/div>\n

\n

About Us<\/strong><\/p>\n\n

XVIVO Perfusion AB is a medical technology company which develops solutions and systems for assessing and preserving organs outside the body and for selecting usable organs and maintaining them in optimal condition pending transplantation. The company is headquartered in Gothenburg, Sweden, and has one office in Lund, Sweden and one office in the USA. The XVIVO share is listed on Nasdaq Stockholm and has the ticker symbol XVIVO. More information can be found on the website www.xvivoperfusion.com.<\/a><\/p>\n<\/div>\n

\n

Attachments<\/strong><\/p>\n\n

XVIVO Perfusion strengthens the management team with the addition of a new Commercial Director and R&D Director<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

XVIVO informs today that Johan Holmstr\u00f6m has joined the company as Commercial Director and Charlotte Walldal as R&D Director.\u00a0Both persons…<\/p>\n","protected":false},"template":"","class_list":["post-2838","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-en","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-other"],"acf":[],"yoast_head":"\nXVIVO Perfusion strengthens the management team with the addition of a new Commercial Director and R&D Director - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-strengthens-the-management-team-with-the-addition-of-a-new-commercial-director-and-rd-director\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"XVIVO Perfusion strengthens the management team with the addition of a new Commercial Director and R&D Director - XVIVO\" \/>\n<meta property=\"og:description\" content=\"XVIVO informs today that Johan Holmstr\u00f6m has joined the company as Commercial Director and Charlotte Walldal as R&D Director.\u00a0Both persons...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-strengthens-the-management-team-with-the-addition-of-a-new-commercial-director-and-rd-director\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-perfusion-strengthens-the-management-team-with-the-addition-of-a-new-commercial-director-and-rd-director\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-perfusion-strengthens-the-management-team-with-the-addition-of-a-new-commercial-director-and-rd-director\\\/\",\"name\":\"XVIVO Perfusion strengthens the management team with the addition of a new Commercial Director and R&D Director - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2020-09-04T09:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-perfusion-strengthens-the-management-team-with-the-addition-of-a-new-commercial-director-and-rd-director\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-perfusion-strengthens-the-management-team-with-the-addition-of-a-new-commercial-director-and-rd-director\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-perfusion-strengthens-the-management-team-with-the-addition-of-a-new-commercial-director-and-rd-director\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"XVIVO Perfusion strengthens the management team with the addition of a new Commercial Director and R&D Director\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"XVIVO Perfusion strengthens the management team with the addition of a new Commercial Director and R&D Director - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-strengthens-the-management-team-with-the-addition-of-a-new-commercial-director-and-rd-director\/","og_locale":"en_US","og_type":"article","og_title":"XVIVO Perfusion strengthens the management team with the addition of a new Commercial Director and R&D Director - XVIVO","og_description":"XVIVO informs today that Johan Holmstr\u00f6m has joined the company as Commercial Director and Charlotte Walldal as R&D Director.\u00a0Both persons...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-strengthens-the-management-team-with-the-addition-of-a-new-commercial-director-and-rd-director\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-strengthens-the-management-team-with-the-addition-of-a-new-commercial-director-and-rd-director\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-strengthens-the-management-team-with-the-addition-of-a-new-commercial-director-and-rd-director\/","name":"XVIVO Perfusion strengthens the management team with the addition of a new Commercial Director and R&D Director - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2020-09-04T09:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-strengthens-the-management-team-with-the-addition-of-a-new-commercial-director-and-rd-director\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-strengthens-the-management-team-with-the-addition-of-a-new-commercial-director-and-rd-director\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-strengthens-the-management-team-with-the-addition-of-a-new-commercial-director-and-rd-director\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"XVIVO Perfusion strengthens the management team with the addition of a new Commercial Director and R&D Director"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/2838","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=2838"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}